INVIVIUM CAPITAL
INVIVIUM CAPITAL is a Seed, Series A and Series C+ fund in the US and global investing in AI, biotechnology, medical-devices, drug-discovery and healthcare-tech.
- Stages
- Seed, Series A, Series C+
- Sectors
- AI, biotechnology, medical-devices, drug-discovery, healthcare-tech
- Invests in
- US-wide, global
- Actively investing
- Yes
- Founded
- 2023
Check size not disclosed
Thesis
InVivium Capital is a venture capital firm established in 2023 and headquartered in Chicago, Illinois, dedicated to investing in transformative healthcare and life sciences innovations. Their investment thesis focuses on companies offering "transformative solutions" that provide a "step-change in value" to patients, payers, providers, and the pharmaceutical and medical technology industries. The firm primarily targets the biotechnology and medical device sectors, with a predominant geographic focus on the United States, though opportunistic global investments are also considered. InVivium Capital actively invests across various stages, from early-stage seed to later-stage growth financings, and has participated in Series A and Series C rounds. They also maintain relationships with seed and venture development programs for early engagement.
Common questions
Does INVIVIUM CAPITAL invest at the Seed stage?
Yes. INVIVIUM CAPITAL lists Seed, Series A and Series C+ among the stages it invests in.
Where does INVIVIUM CAPITAL invest?
INVIVIUM CAPITAL invests in the US and global.